Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase NA 1Phase 2/3 1Phase 1 1

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Breast Neoplasms 238Carcinoma, Non-Small-Cell Lung 205Prostatic Neoplasms 137Lung Neoplasms 96Stomach Neoplasms 85Head and Neck Neoplasms 59Squamous Cell Carcinoma of Head and Neck 58Neoplasms 42Neoplasm Metastasis 39Esophageal Neoplasms 36Ovarian Neoplasms 29Pancreatic Neoplasms 27Sarcoma 19Urinary Bladder Neoplasms 18Adenocarcinoma of Lung 18Carcinoma, Squamous Cell 17Triple Negative Breast Neoplasms 15Nasopharyngeal Carcinoma 14Adenocarcinoma 14Carcinoma, Ovarian Epithelial 13Adenocarcinoma Of Esophagus 13Recurrence 12Inflammatory Breast Neoplasms 10Carcinoma, Transitional Cell 10Breast Neoplasms, Male 10Esophageal Squamous Cell Carcinoma 9Laryngeal Neoplasms 8Uterine Cervical Neoplasms 7Nasopharyngeal Neoplasms 7Leiomyosarcoma 7

Interventions

Cisplatin 14Specimen Handling 6Cetuximab 6Surgical Procedures, Operative 5Radiotherapy, Intensity-Modulated 5Magnetic Resonance Spectroscopy 51,2-diaminocyclohexaneplatinum II citrate 5toripalimab 4Radiotherapy 4Platinum 4Docetaxel 4Celecoxib 4pembrolizumab 3X-Rays 3130-nm albumin-bound paclitaxel 3camrelizumab 2Radiotherapy, Image-Guided 2Radiation 2Paclitaxel 2Fluorouracil 2Chemoradiotherapy 2Carboplatin 2Biopsy 2tislelizumab 1sodium thiosulfate 1sacituzumab govitecan 1nimotuzumab 1nedaplatin 1merphos 1ipatasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Hypopharyngeal Neoplasms × Docetaxel × Clear all
NCT06611137 2024-09-26

SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx

Sun Yat-sen University

Phase 2 Recruiting
35 enrolled
Head & Neck

Hypopharyngeal Neoplasms, Laryngeal Neoplasms

NCT04156698 2023-08-09

Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

Eye & ENT Hospital of Fudan University

Phase 2 Unknown
51 enrolled
Head & Neck

Hypopharyngeal Neoplasms

NCT01312350 2019-12-09

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

Samsung Medical Center

Phase 2 Completed
40 enrolled
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms

NCT01516996 2012-03-20

Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer

The Second People's Hospital of Sichuan

Phase 2 Unknown
80 enrolled
Head & Neck

Hypopharyngeal Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡